Lecithin : technological, biological, and therapeutic aspects

LDR 01437nam a22003611a 4500
001 000873432
003 MiAaHDL
005 20210817000000.0
006 m d
007 cr bn ---auaua
008 880908s1987 nyua b 10110 eng c
010 ⊔ ⊔ ‡a87032811
020 ⊔ ⊔ ‡a0306427869
035 ⊔ ⊔ ‡a(MiU)990008734320106381
035 ⊔ ⊔ ‡asdr-miu.990008734320106381
035 ⊔ ⊔ ‡a(OCoLC)17227596
035 ⊔ ⊔ ‡a(CaOTULAS)175695948
035 ⊔ ⊔ ‡a(RLIN)MIUG88-B19166
035 ⊔ ⊔ ‡z(MiU)Aleph000873432
040 ⊔ ⊔ ‡aDNLM/DLC ‡cDLC
050 0 ⊔ ‡aQP752.L4 ‡bI58 1986
060 ⊔ ⊔ ‡aW3 IN7353 4th 1986L ‡aQU 93 159 1986L
082 0 ⊔ ‡a615/.323/322 ‡219
111 2 ⊔ ‡aInternational Colloquium on Lecithin. ‡n(4th : ‡d1986 : ‡cChicago, Ill.)
245 1 0 ‡aLecithin : ‡btechnological, biological, and therapeutic aspects / ‡cedited by Israel Hanin and G. Brian Ansell.
260 ⊔ ⊔ ‡aNew York : ‡bPlenum Press, ‡cc1987.
300 ⊔ ⊔ ‡ax, 196 p. : ‡bill. ; ‡c26 cm.
490 0 ⊔ ‡aAdvances in behavioral biology. ‡vv. 33
500 ⊔ ⊔ ‡a"Proceedings of the Fourth International Colloquium on Lecithin, held September 15-17, 1986, in Chicago, Illinois"--T.p. verso.
504 ⊔ ⊔ ‡aIncludes bibliographies and index.
538 ⊔ ⊔ ‡aMode of access: Internet.
650 ⊔ 2 ‡aPhosphatidylcholines ‡xcongresses.
650 ⊔ 0 ‡aLecithin ‡xAnalysis ‡xCongresses.
650 ⊔ 0 ‡aLecithin ‡xTherapeutic use ‡xcongresses.
650 ⊔ 0 ‡aLecithin ‡xPhysiological effect ‡xCongresses.
700 1 ⊔ ‡aAnsell, G. B. ‡q(Gordon Brian)
700 1 ⊔ ‡aHanin, Israel.
CID ⊔ ⊔ ‡a000873432
DAT 0 ⊔ ‡a19880908000000.0 ‡b20210817000000.0
DAT 1 ⊔ ‡a20210919140713.0 ‡b2024-02-28T18:40:59Z
DAT 2 ⊔ ‡a2024-02-28T18:30:02Z
CAT ⊔ ⊔ ‡aSDR-MIU ‡dALMA ‡lprepare.pl-004-008
FMT ⊔ ⊔ ‡aBK
HOL ⊔ ⊔ ‡0sdr-miu.990008734320106381 ‡aMiU ‡bSDR ‡cMIU ‡pmdp.39015012546621 ‡sMIU ‡zv.33 ‡1990008734320106381
974 ⊔ ⊔ ‡bMIU ‡cMIU ‡d20240228 ‡sgoogle ‡umdp.39015012546621 ‡zv.33 ‡y1987 ‡ric ‡qbib ‡tUS bib date1 >= 1929